Holen Sie sich die Stockscreener-App
52.33
3.00%
-1.644
Handel nachbörslich:
52.37
0.044
+0.08%
Schlusskurs vom Vortag:
$53.97
Offen:
$53.47
24-Stunden-Volumen:
836.82K
Relative Volume:
1.31
Marktkapitalisierung:
$2.41B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-146.66M
KGV:
-19.00
EPS:
-2.7541
Netto-Cashflow:
$-133.21M
1W Leistung:
+31.76%
1M Leistung:
+41.95%
6M Leistung:
+57.30%
1J Leistung:
-6.20%
1-Tages-Spanne:
$52.04
$54.44
1-Wochen-Bereich:
$39.86
$54.80
52-Wochen-Spanne:
$26.20
$63.50
Apogee Therapeutics Inc Stock (APGE) Company Profile
Firmenname
Apogee Therapeutics Inc
Sektor
Branche
Telefon
650-394-5230
Adresse
221 CRESCENT ST., WALTHAM
Vergleichen Sie APGE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
APGE
Apogee Therapeutics Inc
|
52.33 | 3.65B | 0 | -146.66M | -133.21M | -2.7541 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Apogee Therapeutics Inc Stock (APGE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-25 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2025-07-07 | Bestätigt | BTIG Research | Buy |
| 2025-03-13 | Eingeleitet | Citigroup | Buy |
| 2024-11-25 | Eingeleitet | Canaccord Genuity | Buy |
| 2024-05-10 | Eingeleitet | BofA Securities | Buy |
| 2023-12-20 | Eingeleitet | BTIG Research | Buy |
| 2023-08-08 | Eingeleitet | Guggenheim | Buy |
| 2023-08-08 | Eingeleitet | Jefferies | Buy |
| 2023-08-08 | Eingeleitet | Stifel | Buy |
| 2023-08-08 | Eingeleitet | TD Cowen | Outperform |
| 2023-08-08 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Apogee Therapeutics Inc Aktie (APGE) Neueste Nachrichten
Does Apogee Therapeutics Inc. (APGE) Have the Potential to Rally 72.52% as Wall Street Analysts Expect? - Yahoo Finance
How moving averages guide Apogee Therapeutics Inc. trading2025 Trading Volume Trends & Real-Time Buy Signal Notifications - newser.com
Will Apogee Therapeutics Inc. stock split attract more investorsJuly 2025 Selloffs & AI Forecast for Swing Trade Picks - newser.com
How to integrate Apogee Therapeutics Inc. into portfolio analysis toolsJuly 2025 Spike Watch & Stepwise Trade Signal Implementation - newser.com
Using data filters to optimize entry into Apogee Therapeutics Inc.Exit Point & Fast Gaining Stock Strategy Reports - newser.com
Best Biotech Stocks To ConsiderOctober 9th - MarketBeat
Real time scanner hits for Apogee Therapeutics Inc. explainedMarket Movers & AI Driven Stock Reports - newser.com
Is it time to cut losses on Apogee Therapeutics Inc.July 2025 Short Interest & Capital Efficiency Focused Strategies - newser.com
Technical signs of recovery in Apogee Therapeutics Inc.Trade Volume Summary & Reliable Volume Spike Trade Alerts - newser.com
Apogee Therapeutics (NASDAQ:APGE) Sees Unusually-High Trading VolumeWhat's Next? - MarketBeat
Apogee Therapeutics closes $345 million public offering By Investing.com - Investing.com Nigeria
Apogee Therapeutics Raises $345 Million From Public Offering - MarketScreener
Apogee Therapeutics Closes $345 Million Public Offering of Common Stock and Pre-Funded Warrants - Quiver Quantitative
Apogee Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $345 Million - GlobeNewswire
$345M Raised — Apogee Therapeutics Closes Offering of 8.05M Shares Including Pre-Funded Warrants - Stock Titan
Apogee Therapeutics (NASDAQ:APGE) Given "Buy" Rating at BTIG Research - MarketBeat
What’s the recovery path for long term holders of Apogee Therapeutics Inc.Swing Trade & Weekly High Conviction Ideas - newser.com
Does Apogee Therapeutics' (APGE) $300 Million Raise Mark a Shift in Its R&D Ambition? - Yahoo Finance
Apogee Therapeutics (APGE): Assessing Valuation Following $300 Million Equity Raise - Yahoo Finance
Apogee Therapeutics raises $323.3 million in public offering on Nasdaq By Investing.com - Investing.com Nigeria
Apogee Therapeutics raises $323.3 million in public offering on Nasdaq - Investing.com India
Apogee Therapeutics Raises $323.3 Million in Offering - TipRanks
Published on: 2025-10-10 05:23:46 - newser.com
Form 424B5 Apogee Therapeutics, - StreetInsider
Reversal indicators forming on Apogee Therapeutics Inc. stockQuarterly Performance Summary & Fast Entry and Exit Trade Plans - newser.com
Apogee Therapeutics' (APGE) "Sell (D-)" Rating Reiterated at Weiss Ratings - MarketBeat
Why Apogee Therapeutics Stock Triumphed on Thursday - The Globe and Mail
Why Apogee Therapeutics Stock Triumphed on Thursday - The Motley Fool
Delta Air Lines, Costco rise premarket; Apogee Therapeutics slips - Investing.com
Delta Air Lines, Tilray Brands, UiPath, Akero Therapeutics, Apogee Therapeutics: Stocks Making The Biggest Moves Today - Stocktwits
Delta Air Lines, Costco rise premarket; Apogee Therapeutics slips By Investing.com - Investing.com Australia
Helen of Troy, Ferrari, Apogee Therapeutics And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Benzinga
Biggest stock movers Thursday: TLRY, AKRO, DAL, and more (APGE:NASDAQ) - Seeking Alpha
Why Richardson Electronics Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket - Benzinga
Published on: 2025-10-09 03:41:55 - newser.com
Apogee Therapeutics prices $300 million public offering By Investing.com - Investing.com Australia
Apogee Therapeutics prices $300 million public offering - Investing.com
Apogee Therapeutics, Inc. announces pricing of $300 million underwritten public offering - MarketScreener
$300M Offering: Apogee Therapeutics Prices 6.95M Shares; Includes Pre-funded Warrants Exercisable Immediately - Stock Titan
Apogee Therapeutics, Inc. Announces Pricing of $300 Million Underwritten Public Offering - Yahoo Finance
Apogee Therapeutics launches common stock public offering By Investing.com - Investing.com Nigeria
Apogee Therapeutics announces proposed underwritten public offering - MarketScreener
Apogee Therapeutics stock falls after announcing proposed public offering By Investing.com - Investing.com Canada
Apogee Therapeutics Launches Public Offering - MarketScreener
Apogee Therapeutics drops on stock offering launch - TradingView
Apogee Therapeutics launches common stock public offering - Investing.com
Apogee Therapeutics, Inc. Announces Underwritten Public Offering of Common Stock and Pre-Funded Warrants - Quiver Quantitative
Apogee Therapeutics, Inc. Announces Proposed Underwritten Public Offering - GlobeNewswire
15% Overallotment Option — Apogee Therapeutics Commences Public Offering to Fund Trials - Stock Titan
Apogee Therapeutics (NASDAQ:APGE) Trading Up 6.9%Here's What Happened - MarketBeat
Published on: 2025-10-05 04:04:42 - newser.com
Finanzdaten der Apogee Therapeutics Inc-Aktie (APGE)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.47%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):